Better Therapeutics is developing prescription digital therapeutics for behavioral therapy to address the root causes of cardiometabolic disease.
Better Therapeutics plans to go public via a merger with Mountain Crest Acquisition Corporation II, a special purpose acquisition company (SPAC), by the end of the month.
On 12 October, the San Francisco-based prescription digital therapeutics (PDT) company completed filings with the US Securities and Exchange Commission to complete the merger, which was originally proposed in...
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
